Efectos del reishi (Ganoderma lucidum) en pacientes con fibromialgia

Abstract

Fibromyalgia is a chronic syndrome of unknown etiology characterized by widespread musculoskeletal pain which affects between 2% and 5% of the world population. The main symptoms are fatigue, decreased physical fitness, poor sleep and depression, among many others. To date, it has not been identified an effective treatment for this syndrome yet. Reishi is the common name of a mushroom produced by the fungus called Ganoderma lucidum (Curt .: Fr.) P. Karst. Different studies have demonstrated that the fungus has got antinociceptive properties and could improve the quality and quantity of sleep, raise the defense levels and increase physical performance. The main objective of the study was to evaluate the effects of six grams of reishi on: pain, quality and quantity of sleep and the inability of patients with fibromyalgia. Secondly, we have evaluated the effects on: happiness, depression, health related quality of life, perception of improvement, fitness, blood glucose, cholesterol and triglycerides, blood pressure and body composition. Seventy fibromyalgic patients were included in a randomized clinical trial with an experimental group and an active placebo group for the pain variable. Results showed that 6 daily grams of reishi decrease the impact of fibromyalgia and improve the following variables: sleep quality, happiness, perception of global clinical improvement, aerobic endurance, speed and flexibility of the lower limb. In addition, the reishi may lower pain and depression levels. In conclusion this study open a new line of research in the treatment of fibromyalgia.